Chris Woodall

Chris Woodall is the Founder and CEO of BluTest Laboratories Limited, with a strong focus on developing standards for biocidal and antiseptic agents.

He is actively involved in various organizations and committees such as BSI CH 216, Commite Europeen de Normalisation TC 216 WG2, TC 216 Virus Task Group, and TC 216 Sporicidal Task Group, contributing significantly to the field.

Chris Woodall's work includes participation in ring trials for the OECD, aiming to establish international standards for biocides and antiseptics.

He is a Member of The Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection/Hospital Infection Society Sporicide Taskforce, showcasing his dedication to advancing healthcare practices.

In addition to his entrepreneurial role at BluTest Laboratories Limited, Chris Woodall serves as an Honorary Clinical Senior Lecturer at the College of Medical, Veterinary and Life Sciences, University of Glasgow, UK, bringing both academic expertise and practical experience to his work.

Chris Woodall pursued his academic journey by studying Molecular Biology for his PhD at the University of Southampton, laying a strong foundation for his career in the scientific and healthcare sectors.

With a diverse professional background that includes positions as CEO at BluTest Laboratories Limited, Director at BluScientific Test Data, Lecturer at GCU, and Senior Research Fellow at University of Edinburgh, Chris Woodall has amassed a wealth of experience and knowledge in the field.